Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs13387042

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr2:217041109 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
A>C / A>G / A>T
Variation Type
SNV Single Nucleotide Variation
Frequency
G=0.483686 (166058/343318, ALFA)
G=0.450425 (119223/264690, TOPMED)
G=0.436131 (61074/140036, GnomAD) (+ 20 more)
G=0.48469 (38144/78698, PAGE_STUDY)
A=0.10642 (3007/28256, 14KJPN)
A=0.10626 (1781/16760, 8.3KJPN)
A=0.4842 (3101/6404, 1000G_30x)
A=0.4742 (2375/5008, 1000G)
G=0.4384 (1964/4480, Estonian)
G=0.4930 (1900/3854, ALSPAC)
G=0.4873 (1807/3708, TWINSUK)
A=0.0949 (278/2930, KOREAN)
A=0.4107 (856/2084, HGDP_Stanford)
G=0.4778 (904/1892, HapMap)
G=0.4886 (555/1136, Daghestan)
G=0.487 (486/998, GoNL)
G=0.445 (267/600, NorthernSweden)
A=0.198 (90/454, SGDP_PRJ)
G=0.440 (95/216, Qatari)
A=0.071 (15/210, Vietnamese)
A=0.47 (42/90, Ancient Sardinia)
A=0.32 (14/44, Siberian)
G=0.47 (19/40, GENOME_DK)
Clinical Significance
Not Reported in ClinVar
Gene : Consequence
IGFBP-AS1 : Intron Variant
LOC105373874 : Non Coding Transcript Variant
Publications
134 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 348566 A=0.516886 G=0.483114 0.274146 0.240373 0.485481 32
European Sub 303004 A=0.522264 G=0.477736 0.272828 0.228301 0.498871 0
African Sub 12242 A=0.73150 G=0.26850 0.534717 0.07172 0.393563 0
African Others Sub 456 A=0.818 G=0.182 0.679825 0.04386 0.276316 1
African American Sub 11786 A=0.72815 G=0.27185 0.529102 0.072798 0.398099 0
Asian Sub 6922 A=0.1024 G=0.8976 0.009535 0.804681 0.185784 0
East Asian Sub 4984 A=0.0999 G=0.9001 0.008828 0.808989 0.182183 0
Other Asian Sub 1938 A=0.1089 G=0.8911 0.011352 0.793602 0.195046 0
Latin American 1 Sub 1074 A=0.5847 G=0.4153 0.340782 0.171322 0.487896 0
Latin American 2 Sub 3160 A=0.3655 G=0.6345 0.143671 0.412658 0.443671 2
South Asian Sub 5226 A=0.5515 G=0.4485 0.306927 0.20398 0.489093 0
Other Sub 16938 A=0.44822 G=0.55178 0.227536 0.33109 0.441374 32


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
Allele Frequency Aggregator Total Global 343318 A=0.516314 G=0.483686
Allele Frequency Aggregator European Sub 299732 A=0.522413 G=0.477587
Allele Frequency Aggregator Other Sub 16116 A=0.44720 G=0.55280
Allele Frequency Aggregator African Sub 11088 A=0.73007 G=0.26993
Allele Frequency Aggregator Asian Sub 6922 A=0.1024 G=0.8976
Allele Frequency Aggregator South Asian Sub 5226 A=0.5515 G=0.4485
Allele Frequency Aggregator Latin American 2 Sub 3160 A=0.3655 G=0.6345
Allele Frequency Aggregator Latin American 1 Sub 1074 A=0.5847 G=0.4153
TopMed Global Study-wide 264690 A=0.549575 G=0.450425
gnomAD - Genomes Global Study-wide 140036 A=0.563869 G=0.436131
gnomAD - Genomes European Sub 75848 A=0.51644 G=0.48356
gnomAD - Genomes African Sub 41948 A=0.73083 G=0.26917
gnomAD - Genomes American Sub 13640 A=0.43065 G=0.56935
gnomAD - Genomes Ashkenazi Jewish Sub 3322 A=0.5536 G=0.4464
gnomAD - Genomes East Asian Sub 3126 A=0.0934 G=0.9066
gnomAD - Genomes Other Sub 2152 A=0.5246 G=0.4754
The PAGE Study Global Study-wide 78698 A=0.51531 G=0.48469
The PAGE Study AfricanAmerican Sub 32514 A=0.72455 G=0.27545
The PAGE Study Mexican Sub 10808 A=0.33438 G=0.66562
The PAGE Study Asian Sub 8318 A=0.1076 G=0.8924
The PAGE Study PuertoRican Sub 7918 A=0.5121 G=0.4879
The PAGE Study NativeHawaiian Sub 4534 A=0.2662 G=0.7338
The PAGE Study Cuban Sub 4230 A=0.5574 G=0.4426
The PAGE Study Dominican Sub 3828 A=0.5964 G=0.4036
The PAGE Study CentralAmerican Sub 2450 A=0.3612 G=0.6388
The PAGE Study SouthAmerican Sub 1982 A=0.3431 G=0.6569
The PAGE Study NativeAmerican Sub 1260 A=0.4762 G=0.5238
The PAGE Study SouthAsian Sub 856 A=0.489 G=0.511
14KJPN JAPANESE Study-wide 28256 A=0.10642 G=0.89358
8.3KJPN JAPANESE Study-wide 16760 A=0.10626 G=0.89374
1000Genomes_30x Global Study-wide 6404 A=0.4842 G=0.5158
1000Genomes_30x African Sub 1786 A=0.7766 G=0.2234
1000Genomes_30x Europe Sub 1266 A=0.5269 G=0.4731
1000Genomes_30x South Asian Sub 1202 A=0.4809 G=0.5191
1000Genomes_30x East Asian Sub 1170 A=0.0949 G=0.9051
1000Genomes_30x American Sub 980 A=0.365 G=0.635
1000Genomes Global Study-wide 5008 A=0.4742 G=0.5258
1000Genomes African Sub 1322 A=0.7784 G=0.2216
1000Genomes East Asian Sub 1008 A=0.0972 G=0.9028
1000Genomes Europe Sub 1006 A=0.5199 G=0.4801
1000Genomes South Asian Sub 978 A=0.484 G=0.516
1000Genomes American Sub 694 A=0.363 G=0.637
Genetic variation in the Estonian population Estonian Study-wide 4480 A=0.5616 G=0.4384
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 A=0.5070 G=0.4930
UK 10K study - Twins TWIN COHORT Study-wide 3708 A=0.5127 G=0.4873
KOREAN population from KRGDB KOREAN Study-wide 2930 A=0.0949 C=0.0000, G=0.9051, T=0.0000
HGDP-CEPH-db Supplement 1 Global Study-wide 2084 A=0.4107 G=0.5893
HGDP-CEPH-db Supplement 1 Est_Asia Sub 470 A=0.134 G=0.866
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 A=0.507 G=0.493
HGDP-CEPH-db Supplement 1 Middle_Est Sub 350 A=0.634 G=0.366
HGDP-CEPH-db Supplement 1 Europe Sub 320 A=0.531 G=0.469
HGDP-CEPH-db Supplement 1 Africa Sub 242 A=0.760 G=0.240
HGDP-CEPH-db Supplement 1 America Sub 216 A=0.032 G=0.968
HGDP-CEPH-db Supplement 1 Oceania Sub 72 A=0.00 G=1.00
HapMap Global Study-wide 1892 A=0.5222 G=0.4778
HapMap American Sub 770 A=0.464 G=0.536
HapMap African Sub 692 A=0.760 G=0.240
HapMap Asian Sub 254 A=0.110 G=0.890
HapMap Europe Sub 176 A=0.438 G=0.562
Genome-wide autozygosity in Daghestan Global Study-wide 1136 A=0.5114 G=0.4886
Genome-wide autozygosity in Daghestan Daghestan Sub 628 A=0.490 G=0.510
Genome-wide autozygosity in Daghestan Near_East Sub 144 A=0.618 G=0.382
Genome-wide autozygosity in Daghestan Central Asia Sub 122 A=0.451 G=0.549
Genome-wide autozygosity in Daghestan Europe Sub 108 A=0.537 G=0.463
Genome-wide autozygosity in Daghestan South Asian Sub 98 A=0.46 G=0.54
Genome-wide autozygosity in Daghestan Caucasus Sub 36 A=0.72 G=0.28
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 A=0.513 G=0.487
Northern Sweden ACPOP Study-wide 600 A=0.555 G=0.445
SGDP_PRJ Global Study-wide 454 A=0.198 G=0.802
Qatari Global Study-wide 216 A=0.560 G=0.440
A Vietnamese Genetic Variation Database Global Study-wide 210 A=0.071 G=0.929
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 90 A=0.47 G=0.53
Siberian Global Study-wide 44 A=0.32 G=0.68
The Danish reference pan genome Danish Study-wide 40 A=0.53 G=0.47
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 2 NC_000002.12:g.217041109A>C
GRCh38.p14 chr 2 NC_000002.12:g.217041109A>G
GRCh38.p14 chr 2 NC_000002.12:g.217041109A>T
GRCh37.p13 chr 2 NC_000002.11:g.217905832A>C
GRCh37.p13 chr 2 NC_000002.11:g.217905832A>G
GRCh37.p13 chr 2 NC_000002.11:g.217905832A>T
Gene: LOC105373874, uncharacterized LOC105373874 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
LOC105373874 transcript XR_923878.3:n.7422A>C N/A Non Coding Transcript Variant
LOC105373874 transcript XR_923878.3:n.7422A>G N/A Non Coding Transcript Variant
LOC105373874 transcript XR_923878.3:n.7422A>T N/A Non Coding Transcript Variant
Gene: IGFBP-AS1, uncharacterized IGFBP-AS1 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
IGFBP-AS1 transcript variant X1 XR_001739169.1:n. N/A Intron Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Not Reported in ClinVar
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement A= C G T
GRCh38.p14 chr 2 NC_000002.12:g.217041109= NC_000002.12:g.217041109A>C NC_000002.12:g.217041109A>G NC_000002.12:g.217041109A>T
GRCh37.p13 chr 2 NC_000002.11:g.217905832= NC_000002.11:g.217905832A>C NC_000002.11:g.217905832A>G NC_000002.11:g.217905832A>T
LOC105373874 transcript XR_923878.3:n.7422= XR_923878.3:n.7422A>C XR_923878.3:n.7422A>G XR_923878.3:n.7422A>T
LOC105373874 transcript XR_923878.2:n.7422= XR_923878.2:n.7422A>C XR_923878.2:n.7422A>G XR_923878.2:n.7422A>T
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

155 SubSNP, 23 Frequency submissions
No Submitter Submission ID Date (Build)
1 WUGSC_SSAHASNP ss23059133 Apr 05, 2004 (121)
2 PERLEGEN ss24305990 Sep 20, 2004 (123)
3 ILLUMINA ss66769329 Dec 01, 2006 (127)
4 ILLUMINA ss67077065 Dec 01, 2006 (127)
5 ILLUMINA ss67408171 Dec 01, 2006 (127)
6 ILLUMINA ss70423602 May 17, 2007 (127)
7 ILLUMINA ss70604189 May 26, 2008 (130)
8 ILLUMINA ss71150258 May 17, 2007 (127)
9 ILLUMINA ss75780405 Dec 07, 2007 (129)
10 KRIBB_YJKIM ss85319117 Dec 16, 2007 (130)
11 BCMHGSC_JDW ss91547334 Mar 24, 2008 (129)
12 SNP500CANCER ss105438120 Feb 06, 2009 (130)
13 BGI ss106160999 Feb 06, 2009 (130)
14 1000GENOMES ss110765414 Jan 25, 2009 (130)
15 ILLUMINA-UK ss118078623 Feb 14, 2009 (130)
16 ILLUMINA ss121644730 Dec 01, 2009 (131)
17 ENSEMBL ss138630771 Dec 01, 2009 (131)
18 ILLUMINA ss153366329 Dec 01, 2009 (131)
19 GMI ss154710990 Dec 01, 2009 (131)
20 ILLUMINA ss159255585 Dec 01, 2009 (131)
21 ILLUMINA ss160334496 Dec 01, 2009 (131)
22 COMPLETE_GENOMICS ss165905519 Jul 04, 2010 (132)
23 ILLUMINA ss170368628 Jul 04, 2010 (132)
24 ILLUMINA ss172406627 Jul 04, 2010 (132)
25 BUSHMAN ss201741646 Jul 04, 2010 (132)
26 1000GENOMES ss211086516 Jul 14, 2010 (132)
27 1000GENOMES ss219813964 Jul 14, 2010 (132)
28 1000GENOMES ss231587624 Jul 14, 2010 (132)
29 1000GENOMES ss239045956 Jul 15, 2010 (132)
30 GMI ss276898769 May 04, 2012 (137)
31 PAGE_STUDY ss469414475 May 04, 2012 (137)
32 PAGE_STUDY ss469415190 May 04, 2012 (137)
33 PAGE_STUDY ss469996423 May 04, 2012 (137)
34 ILLUMINA ss479919825 May 04, 2012 (137)
35 ILLUMINA ss479927651 May 04, 2012 (137)
36 ILLUMINA ss480556528 Sep 08, 2015 (146)
37 ILLUMINA ss484758112 May 04, 2012 (137)
38 EXOME_CHIP ss491330980 May 04, 2012 (137)
39 ILLUMINA ss536850784 Sep 08, 2015 (146)
40 TISHKOFF ss556221008 Apr 25, 2013 (138)
41 SSMP ss649887033 Apr 25, 2013 (138)
42 ILLUMINA ss778800844 Sep 08, 2015 (146)
43 ILLUMINA ss780681798 Sep 08, 2015 (146)
44 ILLUMINA ss782825784 Sep 08, 2015 (146)
45 ILLUMINA ss783355130 Sep 08, 2015 (146)
46 ILLUMINA ss783790678 Sep 08, 2015 (146)
47 ILLUMINA ss825392876 Jul 19, 2016 (147)
48 ILLUMINA ss832079185 Sep 08, 2015 (146)
49 ILLUMINA ss832767829 Jul 13, 2019 (153)
50 ILLUMINA ss834261014 Sep 08, 2015 (146)
51 EVA-GONL ss977963478 Aug 21, 2014 (142)
52 JMKIDD_LAB ss1069943202 Aug 21, 2014 (142)
53 1000GENOMES ss1301655309 Aug 21, 2014 (142)
54 HAMMER_LAB ss1397320520 Sep 08, 2015 (146)
55 DDI ss1428911864 Apr 01, 2015 (144)
56 CLINVAR ss1457608616 Nov 23, 2014 (142)
57 EVA_GENOME_DK ss1579324218 Apr 01, 2015 (144)
58 EVA_DECODE ss1587418578 Apr 01, 2015 (144)
59 EVA_UK10K_ALSPAC ss1605798638 Apr 01, 2015 (144)
60 EVA_UK10K_TWINSUK ss1648792671 Apr 01, 2015 (144)
61 EVA_SVP ss1712530929 Apr 01, 2015 (144)
62 ILLUMINA ss1752338576 Sep 08, 2015 (146)
63 ILLUMINA ss1752338577 Sep 08, 2015 (146)
64 HAMMER_LAB ss1798359355 Sep 08, 2015 (146)
65 ILLUMINA ss1917759575 Feb 12, 2016 (147)
66 WEILL_CORNELL_DGM ss1921208099 Feb 12, 2016 (147)
67 ILLUMINA ss1946066168 Feb 12, 2016 (147)
68 ILLUMINA ss1946066169 Feb 12, 2016 (147)
69 ILLUMINA ss1958504224 Feb 12, 2016 (147)
70 ILLUMINA ss1958504226 Feb 12, 2016 (147)
71 GENOMED ss1969025669 Jul 19, 2016 (147)
72 JJLAB ss2021152425 Sep 14, 2016 (149)
73 USC_VALOUEV ss2149213866 Dec 20, 2016 (150)
74 HUMAN_LONGEVITY ss2239171062 Dec 20, 2016 (150)
75 SYSTEMSBIOZJU ss2625075582 Nov 08, 2017 (151)
76 ILLUMINA ss2633739902 Nov 08, 2017 (151)
77 ILLUMINA ss2633739903 Nov 08, 2017 (151)
78 ILLUMINA ss2633739904 Nov 08, 2017 (151)
79 ILLUMINA ss2635101340 Nov 08, 2017 (151)
80 GRF ss2703862873 Nov 08, 2017 (151)
81 ILLUMINA ss2710925699 Nov 08, 2017 (151)
82 GNOMAD ss2786359059 Nov 08, 2017 (151)
83 AFFY ss2985199543 Nov 08, 2017 (151)
84 AFFY ss2985819486 Nov 08, 2017 (151)
85 SWEGEN ss2991362259 Nov 08, 2017 (151)
86 ILLUMINA ss3022068825 Nov 08, 2017 (151)
87 ILLUMINA ss3022068826 Nov 08, 2017 (151)
88 BIOINF_KMB_FNS_UNIBA ss3024334060 Nov 08, 2017 (151)
89 CSHL ss3344742566 Nov 08, 2017 (151)
90 ILLUMINA ss3625776407 Oct 11, 2018 (152)
91 ILLUMINA ss3628286561 Oct 11, 2018 (152)
92 ILLUMINA ss3628286562 Oct 11, 2018 (152)
93 ILLUMINA ss3631699910 Oct 11, 2018 (152)
94 ILLUMINA ss3633234400 Oct 11, 2018 (152)
95 ILLUMINA ss3633947581 Oct 11, 2018 (152)
96 ILLUMINA ss3634811918 Oct 11, 2018 (152)
97 ILLUMINA ss3634811919 Oct 11, 2018 (152)
98 ILLUMINA ss3635633017 Oct 11, 2018 (152)
99 ILLUMINA ss3636501791 Oct 11, 2018 (152)
100 ILLUMINA ss3637385035 Oct 11, 2018 (152)
101 ILLUMINA ss3638318741 Oct 11, 2018 (152)
102 ILLUMINA ss3639162793 Oct 11, 2018 (152)
103 ILLUMINA ss3639594812 Oct 11, 2018 (152)
104 ILLUMINA ss3640519217 Oct 11, 2018 (152)
105 ILLUMINA ss3640519218 Oct 11, 2018 (152)
106 ILLUMINA ss3641120897 Oct 11, 2018 (152)
107 ILLUMINA ss3641417017 Oct 11, 2018 (152)
108 ILLUMINA ss3643283483 Oct 11, 2018 (152)
109 ILLUMINA ss3644768834 Oct 11, 2018 (152)
110 ILLUMINA ss3644768835 Oct 11, 2018 (152)
111 URBANLAB ss3647274792 Oct 11, 2018 (152)
112 ILLUMINA ss3652519722 Oct 11, 2018 (152)
113 ILLUMINA ss3652519723 Oct 11, 2018 (152)
114 ILLUMINA ss3653967253 Oct 11, 2018 (152)
115 EGCUT_WGS ss3659257709 Jul 13, 2019 (153)
116 EVA_DECODE ss3706027688 Jul 13, 2019 (153)
117 ILLUMINA ss3725871951 Jul 13, 2019 (153)
118 ACPOP ss3729374553 Jul 13, 2019 (153)
119 ILLUMINA ss3744190604 Jul 13, 2019 (153)
120 ILLUMINA ss3744486855 Jul 13, 2019 (153)
121 ILLUMINA ss3745111735 Jul 13, 2019 (153)
122 ILLUMINA ss3745111736 Jul 13, 2019 (153)
123 EVA ss3758086273 Jul 13, 2019 (153)
124 PAGE_CC ss3770985538 Jul 13, 2019 (153)
125 ILLUMINA ss3772608257 Jul 13, 2019 (153)
126 ILLUMINA ss3772608258 Jul 13, 2019 (153)
127 KHV_HUMAN_GENOMES ss3802450847 Jul 13, 2019 (153)
128 EVA ss3827507740 Apr 25, 2020 (154)
129 EVA ss3837173428 Apr 25, 2020 (154)
130 EVA ss3842595241 Apr 25, 2020 (154)
131 HGDP ss3847651082 Apr 25, 2020 (154)
132 SGDP_PRJ ss3854599357 Apr 25, 2020 (154)
133 KRGDB ss3900318944 Apr 25, 2020 (154)
134 EVA ss3984953798 Apr 26, 2021 (155)
135 EVA ss4017049532 Apr 26, 2021 (155)
136 TOPMED ss4544736948 Apr 26, 2021 (155)
137 TOMMO_GENOMICS ss5156507436 Apr 26, 2021 (155)
138 1000G_HIGH_COVERAGE ss5252042215 Oct 12, 2022 (156)
139 EVA ss5314808321 Oct 12, 2022 (156)
140 EVA ss5336052347 Oct 12, 2022 (156)
141 HUGCELL_USP ss5451651792 Oct 12, 2022 (156)
142 EVA ss5506798841 Oct 12, 2022 (156)
143 1000G_HIGH_COVERAGE ss5529395563 Oct 12, 2022 (156)
144 SANFORD_IMAGENETICS ss5624471817 Oct 12, 2022 (156)
145 SANFORD_IMAGENETICS ss5630958170 Oct 12, 2022 (156)
146 TOMMO_GENOMICS ss5687393647 Oct 12, 2022 (156)
147 EVA ss5799560340 Oct 12, 2022 (156)
148 YY_MCH ss5803223153 Oct 12, 2022 (156)
149 EVA ss5821595493 Oct 12, 2022 (156)
150 EVA ss5847205234 Oct 12, 2022 (156)
151 EVA ss5847902589 Oct 12, 2022 (156)
152 EVA ss5852952634 Oct 12, 2022 (156)
153 EVA ss5934716465 Oct 12, 2022 (156)
154 EVA ss5957214270 Oct 12, 2022 (156)
155 EVA ss5979599680 Oct 12, 2022 (156)
156 1000Genomes NC_000002.11 - 217905832 Oct 11, 2018 (152)
157 1000Genomes_30x NC_000002.12 - 217041109 Oct 12, 2022 (156)
158 The Avon Longitudinal Study of Parents and Children NC_000002.11 - 217905832 Oct 11, 2018 (152)
159 Genome-wide autozygosity in Daghestan NC_000002.10 - 217614077 Apr 25, 2020 (154)
160 Genetic variation in the Estonian population NC_000002.11 - 217905832 Oct 11, 2018 (152)
161 The Danish reference pan genome NC_000002.11 - 217905832 Apr 25, 2020 (154)
162 gnomAD - Genomes NC_000002.12 - 217041109 Apr 26, 2021 (155)
163 Genome of the Netherlands Release 5 NC_000002.11 - 217905832 Apr 25, 2020 (154)
164 HGDP-CEPH-db Supplement 1 NC_000002.10 - 217614077 Apr 25, 2020 (154)
165 HapMap NC_000002.12 - 217041109 Apr 25, 2020 (154)
166 KOREAN population from KRGDB NC_000002.11 - 217905832 Apr 25, 2020 (154)
167 Northern Sweden NC_000002.11 - 217905832 Jul 13, 2019 (153)
168 The PAGE Study NC_000002.12 - 217041109 Jul 13, 2019 (153)
169 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000002.11 - 217905832 Apr 26, 2021 (155)
170 Qatari NC_000002.11 - 217905832 Apr 25, 2020 (154)
171 SGDP_PRJ NC_000002.11 - 217905832 Apr 25, 2020 (154)
172 Siberian NC_000002.11 - 217905832 Apr 25, 2020 (154)
173 8.3KJPN NC_000002.11 - 217905832 Apr 26, 2021 (155)
174 14KJPN NC_000002.12 - 217041109 Oct 12, 2022 (156)
175 TopMed NC_000002.12 - 217041109 Apr 26, 2021 (155)
176 UK 10K study - Twins NC_000002.11 - 217905832 Oct 11, 2018 (152)
177 A Vietnamese Genetic Variation Database NC_000002.11 - 217905832 Jul 13, 2019 (153)
178 ALFA NC_000002.12 - 217041109 Apr 26, 2021 (155)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs17834522 Oct 07, 2004 (123)
rs61418054 May 26, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
7496338, ss3900318944 NC_000002.11:217905831:A:C NC_000002.12:217041108:A:C (self)
ss3639162793, ss3639594812 NC_000002.9:217731337:A:G NC_000002.12:217041108:A:G (self)
270288, 328974, ss91547334, ss110765414, ss118078623, ss165905519, ss201741646, ss211086516, ss276898769, ss479919825, ss825392876, ss1397320520, ss1587418578, ss1712530929, ss2635101340, ss3643283483, ss3847651082 NC_000002.10:217614076:A:G NC_000002.12:217041108:A:G (self)
12760930, 7057376, 4995957, 5489157, 3095775, 7496338, 2659418, 179725, 3250029, 6616337, 1730220, 14476743, 7057376, 1534006, ss219813964, ss231587624, ss239045956, ss479927651, ss480556528, ss484758112, ss491330980, ss536850784, ss556221008, ss649887033, ss778800844, ss780681798, ss782825784, ss783355130, ss783790678, ss832079185, ss832767829, ss834261014, ss977963478, ss1069943202, ss1301655309, ss1428911864, ss1579324218, ss1605798638, ss1648792671, ss1752338576, ss1752338577, ss1798359355, ss1917759575, ss1921208099, ss1946066168, ss1946066169, ss1958504224, ss1958504226, ss1969025669, ss2021152425, ss2149213866, ss2625075582, ss2633739902, ss2633739903, ss2633739904, ss2703862873, ss2710925699, ss2786359059, ss2985199543, ss2985819486, ss2991362259, ss3022068825, ss3022068826, ss3344742566, ss3625776407, ss3628286561, ss3628286562, ss3631699910, ss3633234400, ss3633947581, ss3634811918, ss3634811919, ss3635633017, ss3636501791, ss3637385035, ss3638318741, ss3640519217, ss3640519218, ss3641120897, ss3641417017, ss3644768834, ss3644768835, ss3652519722, ss3652519723, ss3653967253, ss3659257709, ss3729374553, ss3744190604, ss3744486855, ss3745111735, ss3745111736, ss3758086273, ss3772608257, ss3772608258, ss3827507740, ss3837173428, ss3854599357, ss3900318944, ss3984953798, ss4017049532, ss5156507436, ss5314808321, ss5336052347, ss5506798841, ss5624471817, ss5630958170, ss5799560340, ss5821595493, ss5847205234, ss5847902589, ss5957214270, ss5979599680 NC_000002.11:217905831:A:G NC_000002.12:217041108:A:G (self)
16921498, 91000586, 2011797, 207007, 21230751, 348559827, 8451457912, ss1457608616, ss2239171062, ss3024334060, ss3647274792, ss3706027688, ss3725871951, ss3770985538, ss3802450847, ss3842595241, ss4544736948, ss5252042215, ss5451651792, ss5529395563, ss5687393647, ss5803223153, ss5852952634, ss5934716465 NC_000002.12:217041108:A:G NC_000002.12:217041108:A:G (self)
ss23059133 NT_005403.14:68115246:A:G NC_000002.12:217041108:A:G (self)
ss24305990, ss66769329, ss67077065, ss67408171, ss70423602, ss70604189, ss71150258, ss75780405, ss85319117, ss105438120, ss106160999, ss121644730, ss138630771, ss153366329, ss154710990, ss159255585, ss160334496, ss170368628, ss172406627, ss469414475, ss469415190, ss469996423 NT_005403.17:68115249:A:G NC_000002.12:217041108:A:G (self)
7496338, ss3900318944 NC_000002.11:217905831:A:T NC_000002.12:217041108:A:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

134 citations for rs13387042
PMID Title Author Year Journal
17529974 Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Stacey SN et al. 2007 Nature genetics
18612136 Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. Gail MH et al. 2008 Journal of the National Cancer Institute
18772892 Can genes for mammographic density inform cancer aetiology? Kelemen LE et al. 2008 Nature reviews. Cancer
18785201 Novel breast cancer risk alleles and endometrial cancer risk. McGrath M et al. 2008 International journal of cancer
18973230 Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. Gates MA et al. 2009 International journal of cancer
19088016 Genetic susceptibility loci for breast cancer by estrogen receptor status. Garcia-Closas M et al. 2008 Clinical cancer research
19092773 Breast cancer susceptibility: current knowledge and implications for genetic counselling. Ripperger T et al. 2009 European journal of human genetics
19232126 Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort. Woolcott CG et al. 2009 Breast cancer research
19330030 A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Thomas G et al. 2009 Nature genetics
19519208 Polygenic susceptibility to breast cancer: current state-of-the-art. Ghoussaini M et al. 2009 Future oncology (London, England)
19567422 Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. Milne RL et al. 2009 Journal of the National Cancer Institute
19656774 Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Antoniou AC et al. 2009 Human molecular genetics
19789366 Evaluation of 11 breast cancer susceptibility loci in African-American women. Zheng W et al. 2009 Cancer epidemiology, biomarkers & prevention
19843326 Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Neuhausen SL et al. 2009 Breast cancer research
19931039 Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. Yang Q et al. 2009 American journal of human genetics
20056641 Multiple genetic variants in telomere pathway genes and breast cancer risk. Shen J et al. 2010 Cancer epidemiology, biomarkers & prevention
20085711 Leveraging genetic variability across populations for the identification of causal variants. Zaitlen N et al. 2010 American journal of human genetics
20146796 Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Mavaddat N et al. 2010 Breast cancer research
20233625 Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies. Darcy KM et al. 2010 Gynecologic oncology
20237344 Performance of common genetic variants in breast-cancer risk models. Wacholder S et al. 2010 The New England journal of medicine
20418484 Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Wang X et al. 2010 Human molecular genetics
20453838 Genome-wide association study identifies five new breast cancer susceptibility loci. Turnbull C et al. 2010 Nature genetics
20484103 Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. Zheng W et al. 2010 Journal of the National Cancer Institute
20505153 A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. Ioannidis JP et al. 2010 Journal of the National Cancer Institute
20554749 FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Barnholtz-Sloan JS et al. 2010 Carcinogenesis
20585100 Genome-wide association studies of cancer. Stadler ZK et al. 2010 Journal of clinical oncology
20605201 Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Travis RC et al. 2010 Lancet (London, England)
20664043 Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. Reeves GK et al. 2010 JAMA
20699374 Evaluation of breast cancer susceptibility loci in Chinese women. Long J et al. 2010 Cancer epidemiology, biomarkers & prevention
20956782 Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. Mealiffe ME et al. 2010 Journal of the National Cancer Institute
20957429 Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Comen E et al. 2011 Breast cancer research and treatment
21037853 Breast cancer in the personal genomics era. Ellsworth RE et al. 2010 Current genomics
21049069 Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes? Meindl A et al. 2009 Breast care (Basel, Switzerland)
21102626 Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations. Chen F et al. 2011 European journal of human genetics
21118973 Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Antoniou AC et al. 2010 Cancer research
21132113 Direct-to-Consumer Genetic and Genomic Testing: Preparing Nurse Practitioners for Genomic Healthcare. Loud JT et al. 2010 The journal for nurse practitioners
21194473 Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Milne RL et al. 2010 Breast cancer research
21219822 [Recent progress in genetic variants associated with cancer and their implications in diagnostics development]. Cho WC et al. 2011 Zhongguo fei ai za zhi = Chinese journal of lung cancer
21269472 Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Li Y et al. 2011 Breast cancer research
21445572 Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Peng S et al. 2011 Breast cancer research and treatment
21468051 Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Pashayan N et al. 2011 British journal of cancer
21475998 Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. Slattery ML et al. 2011 Breast cancer research and treatment
21514219 Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Zhang B et al. 2011 The Lancet. Oncology
21596841 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Broeks A et al. 2011 Human molecular genetics
21639959 Annual conference on hereditary cancers 2009 szczecin, poland. 10-11 december 2009. Abstracts. Jakubowska A et al. 2011 Hereditary cancer in clinical practice
21655367 In search of breast cancer culprits: suspecting the suspected and the unsuspected. Dimri GP et al. 2008 Breast cancer
21791674 Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. Campa D et al. 2011 Journal of the National Cancer Institute
21795501 Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Hutter CM et al. 2011 Cancer epidemiology, biomarkers & prevention
21844186 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Stevens KN et al. 2011 Cancer research
21852243 Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Chen F et al. 2011 Human molecular genetics
21852249 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Figueroa JD et al. 2011 Human molecular genetics
21931568 Genome-wide association study identifies four loci associated with eruption of permanent teeth. Geller F et al. 2011 PLoS genetics
21949660 Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men. Orr N et al. 2011 PLoS genetics
21965274 Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Healey CS et al. 2011 Carcinogenesis
22028405 Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases. Dudbridge F et al. 2012 Cancer epidemiology, biomarkers & prevention
22045194 Combined effect of low-penetrant SNPs on breast cancer risk. Harlid S et al. 2012 British journal of cancer
22053997 Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Mulligan AM et al. 2011 Breast cancer research
22087758 Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Teraoka SN et al. 2011 Breast cancer research
22269215 Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Dai J et al. 2012 Breast cancer research
22287734 Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer. Lin CY et al. 2012 Anticancer research
22314178 Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Darabi H et al. 2012 Breast cancer research
22357627 Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Huo D et al. 2012 Carcinogenesis
22433456 Reproductive aging-associated common genetic variants and the risk of breast cancer. He C et al. 2012 Breast cancer research
22452962 A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Kim HC et al. 2012 Breast cancer research
22454379 Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Vachon CM et al. 2012 Cancer epidemiology, biomarkers & prevention
22532573 The role of genetic breast cancer susceptibility variants as prognostic factors. Fasching PA et al. 2012 Human molecular genetics
22747683 Genetic variants associated with breast size also influence breast cancer risk. Eriksson N et al. 2012 BMC medical genetics
22778704 The association between single-nucleotide polymorphisms of ORAI1 gene and breast cancer in a Taiwanese population. Chang WC et al. 2012 TheScientificWorldJournal
22806168 A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24. Higginbotham KS et al. 2012 Cancer epidemiology, biomarkers & prevention
22867275 Genetic predisposition, parity, age at first childbirth and risk for breast cancer. Butt S et al. 2012 BMC research notes
22910930 Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Shan J et al. 2012 Breast cancer research and treatment
22972951 Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. Hüsing A et al. 2012 Journal of medical genetics
23136140 Genetic susceptibility loci for subtypes of breast cancer in an African American population. Palmer JR et al. 2013 Cancer epidemiology, biomarkers & prevention
23221726 Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study. Li H et al. 2013 American journal of epidemiology
23354978 Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Rinella ES et al. 2013 Human genetics
23474973 Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women. McCarthy AM et al. 2013 Breast cancer research and treatment
23486537 Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. Barzan D et al. 2013 European journal of human genetics
23535825 Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Zheng W et al. 2013 Human molecular genetics
23544014 Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. Nickels S et al. 2013 PLoS genetics
23563089 Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women. Fejerman L et al. 2013 Carcinogenesis
23577780 Associations between single-nucleotide polymorphisms and epidural ropivacaine consumption in patients undergoing breast cancer surgery. Liu J et al. 2013 Genetic testing and molecular biomarkers
23593120 Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. Long J et al. 2013 PloS one
23635555 The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. Bayraktar S et al. 2013 The oncologist
23650637 Deconvoluting complex tissues for expression quantitative trait locus-based analyses. Seo JH et al. 2013 Philosophical transactions of the Royal Society of London. Series B, Biological sciences
23776363 The genetics of breast cancer: risk factors for disease. Collins A et al. 2011 The application of clinical genetics
23893088 The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk. Warren Andersen S et al. 2013 Breast cancer research and treatment
24025454 Hereditary breast cancer: ever more pieces to the polygenic puzzle. Bogdanova N et al. 2013 Hereditary cancer in clinical practice
24086368 An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility. Landa I et al. 2013 PloS one
24171766 Common low-penetrance risk variants associated with breast cancer in Polish women. Ledwoń JK et al. 2013 BMC cancer
24218030 Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach. O'Brien KM et al. 2014 American journal of epidemiology
24242184 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Milne RL et al. 2014 Human molecular genetics
24266904 Breast cancer prediction using genome wide single nucleotide polymorphism data. Hajiloo M et al. 2013 BMC bioinformatics
24359602 Common breast cancer risk variants in the post-COGS era: a comprehensive review. Maxwell KN et al. 2013 Breast cancer research
24373701 Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan. Warren Andersen S et al. 2014 Cancer epidemiology
24510657 Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study. Han MR et al. 2015 Breast cancer (Tokyo, Japan)
24532140 Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population. Elematore I et al. 2014 Molecular biology reports
24743323 Genetic predisposition to in situ and invasive lobular carcinoma of the breast. Sawyer E et al. 2014 PLoS genetics
24771903 Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis. Fasching PA et al. 2013 Geburtshilfe und Frauenheilkunde
24792587 Reproductive windows, genetic loci, and breast cancer risk. Warren Andersen S et al. 2014 Annals of epidemiology
24895409 Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. Barrdahl M et al. 2014 Human molecular genetics
24941967 Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population. Lee CP et al. 2014 Breast cancer research
24943594 Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Milne RL et al. 2014 Human molecular genetics
25027274 Testing calibration of risk models at extremes of disease risk. Song M et al. 2015 Biostatistics (Oxford, England)
25057183 A robust association test for detecting genetic variants with heterogeneous effects. Yu K et al. 2015 Biostatistics (Oxford, England)
25253900 Breast Cancer Risk - Genes, Environment and Clinics. Fasching PA et al. 2011 Geburtshilfe und Frauenheilkunde
25255808 Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. Joshi AD et al. 2014 American journal of epidemiology
25567532 The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms. McCarthy AM et al. 2015 Breast cancer research
25611573 Association of breast cancer risk loci with breast cancer survival. Barrdahl M et al. 2015 International journal of cancer
25881232 Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography. Keller BM et al. 2015 BMC cancer
26070784 Genetic risk variants associated with in situ breast cancer. Campa D et al. 2015 Breast cancer research
26364163 Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women. Fejerman L et al. 2015 Cancer epidemiology, biomarkers & prevention
26510858 Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity. Dorling L et al. 2016 Clinical cancer research
26559640 Automated amplicon design suitable for analysis of DNA variants by melting techniques. Ekstrøm PO et al. 2015 BMC research notes
26757262 Gene-environment interaction and risk of breast cancer. Rudolph A et al. 2016 British journal of cancer
26802016 Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Gaudet MM et al. 2016 Breast cancer research and treatment
26884359 Genetic predisposition to ductal carcinoma in situ of the breast. Petridis C et al. 2016 Breast cancer research
27022606 Associations of Genetic Variants at Nongenic Susceptibility Loci with Breast Cancer Risk and Heterogeneity by Tumor Subtype in Southern Han Chinese Women. Liang H et al. 2016 BioMed research international
27079684 Genome-wide association studies and epigenome-wide association studies go together in cancer control. Verma M et al. 2016 Future oncology (London, England)
27392074 The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study. Dorling L et al. 2016 PloS one
27424552 Genomics era and complex disorders: Implications of GWAS with special reference to coronary artery disease, type 2 diabetes mellitus, and cancers. Pranavchand R et al. 2016 Journal of postgraduate medicine
27814745 Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities. Lindström S et al. 2016 Breast cancer research
27825120 Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach. Zhu Q et al. 2016 Oncotarget
28098224 Association of Genome-Wide Association Study (GWAS) Identified SNPs and Risk of Breast Cancer in an Indian Population. Nagrani R et al. 2017 Scientific reports
28178648 Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer. Kuo SH et al. 2017 Oncotarget
28757652 Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study. Hein A et al. 2017 Geburtshilfe und Frauenheilkunde
28985766 Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations. Jara L et al. 2017 Biological research
29382703 Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future. Lilyquist J et al. 2018 Cancer epidemiology, biomarkers & prevention
30285756 Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer. Fu F et al. 2018 Journal of translational medicine
30781715 Genetic Epidemiology of Breast Cancer in Latin America. Zavala VA et al. 2019 Genes
31125336 Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients. Rath M et al. 2019 PloS one
31605532 Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium. Kapoor PM et al. 2020 International journal of epidemiology
32022527 Synchronous and multiple renal cell carcinoma, clear cell and papillary: An approach to clinically significant genetic abnormalities. Cifuentes-C L et al. 2020 International braz j urol
32269954 Copy number alternations of the 17q23-rs6504950 locus are associated with advanced breast cancers in Taiwanese women. Lin CY et al. 2020 Tzu chi medical journal
32823908 Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer Quae Exempli Causa. Jurj MA et al. 2020 International journal of molecular sciences
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d